Ivan Zekanovic

Zadar, 23000, Croatia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Comparative Value of the Novel Age-Agnostic DIPSS-R Versus the DIPSS for Prognostication in Myelofibrosis: A Multicenter Evaluation and Reclassification Study.

Comparative Value of the Novel Age-Agnostic DIPSS-R Versus the DIPSS for Prognostication in Myelofibrosis: A Multicenter Evaluation and Reclassification Study.

Journal: Cancers

Published: May 31, 2026

Immature Platelet Fraction as a Potential Biomarker of Dysregulated Thrombopoiesis in Philadelphia-Negative Myeloproliferative Neoplasms.

Immature Platelet Fraction as a Potential Biomarker of Dysregulated Thrombopoiesis in Philadelphia-Negative Myeloproliferative Neoplasms.

Journal: Journal of clinical medicine

Published: December 22, 2025

Prevalence of Chronic Obstructive Pulmonary Disease and Asthma in Polycythemia Vera and Essential Thrombocythemia and Its Prognostic Implications.

Prevalence of Chronic Obstructive Pulmonary Disease and Asthma in Polycythemia Vera and Essential Thrombocythemia and Its Prognostic Implications.

Journal: Journal of clinical medicine

Published: October 26, 2025

Extreme Thrombocytosis in Patients with Overt Myelofibrosis and Its Clinical Associations.

Extreme Thrombocytosis in Patients with Overt Myelofibrosis and Its Clinical Associations.

Journal: Cancers

Published: March 12, 2025

Carfilzomib in relapsed/refractory multiple myeloma patients - real world evidence - experiences of the Croatian cooperative group for hematologic diseases (KROHEM).

Carfilzomib in relapsed/refractory multiple myeloma patients - real world evidence - experiences of the Croatian cooperative group for hematologic diseases (KROHEM).

Journal: Cancer treatment and research communications

Published: November 20, 2024

Systemic Inflammatory Index in Polycythemia Vera and Its Prognostic Implications.

Systemic Inflammatory Index in Polycythemia Vera and Its Prognostic Implications.

Journal: Journal of clinical medicine

Published: July 02, 2024

Triple a score (AAA: age, absolute neutrophil count and absolute lymphocyte count) and its prognostic utility in patients with overt fibrotic and prefibrotic myelofibrosis.

Triple a score (AAA: age, absolute neutrophil count and absolute lymphocyte count) and its prognostic utility in patients with overt fibrotic and prefibrotic myelofibrosis.

Journal: Annals of hematology

Published: March 11, 2024

Evaluation of Absolute Neutrophil, Lymphocyte and Platelet Count and Their Ratios as Predictors of Thrombotic Risk in Patients with Prefibrotic and Overt Myelofibrosis.

Evaluation of Absolute Neutrophil, Lymphocyte and Platelet Count and Their Ratios as Predictors of Thrombotic Risk in Patients with Prefibrotic and Overt Myelofibrosis.

Journal: Life (Basel, Switzerland)

Published: March 08, 2024

Glycated hemoglobin (HbA1c) and thrombotic risk in polycythemia vera and essential thrombocythemia.

Glycated hemoglobin (HbA1c) and thrombotic risk in polycythemia vera and essential thrombocythemia.

Journal: Leukemia & lymphoma

Published: January 22, 2024

The triple A model (age, absolute neutrophil count, absolute lymphocyte count-AAA) predicts survival and thrombosis in polycythemia vera.

The triple A model (age, absolute neutrophil count, absolute lymphocyte count-AAA) predicts survival and thrombosis in polycythemia vera.

Journal: American journal of hematology

Published: January 10, 2024

Prolonged Proton Pump Inhibitor Use and Thrombohemorrhagic Risk in Essential Thrombocythemia and Polycythemia Vera Patients Treated with Long-Term Aspirin: A Pilot Study.

Prolonged Proton Pump Inhibitor Use and Thrombohemorrhagic Risk in Essential Thrombocythemia and Polycythemia Vera Patients Treated with Long-Term Aspirin: A Pilot Study.

Journal: Pharmacology

Published: July 25, 2023

Palpable spleen size is differently prognostic in primary and secondary myelofibrosis.

Palpable spleen size is differently prognostic in primary and secondary myelofibrosis.

Journal: Leukemia & lymphoma

Published: February 17, 2023

Showing 1-12 of 33

Last Updated: 09/26/2026